Description
A Randomized, Controlled, Open-label, Phase 3 Study of Melflufen/Dexamethasone Compared With Pomalidomide/Dexamethasone for Patients With Relapsed Refractory Multiple Myeloma Who Are Refractory to Lenalidomide
Contact Name: James Nasman
Please contact NasmanJ@sutterhealth.org about study OCEAN OP-103
Location: REDI (East Bay)
View study details on ClinicalTrials.gov
Principal Investigator
Co-Investigator(s)
Uma Suryadevara, MD, Oleg I. Krijanovski, M.D., Ph.D.
Recruitment Status
Completed
Start Date
February 01, 2019
Related Studies
Advance Care Planning Practices in Caring for Vulnerable Elders with Multiple Chronic Conditions
Investigator(s): Ellis C. Dillon, Ph.D.
Breast Cancer Chemoprevention in Primary Care at Geisinger
Investigators: External PI, Principal Investigator, Xiaowei (Sherry) Yan, PhD, MS
Breast Tumor and Blood markers for Molecular Diagnosis of Breast Diseases and Monitoring of Breast Cancer Treatment and Follow-up
Coverage, Price, and Reimbursement for Multigene Tests for Cancer and Related Conditions
Investigator(s): Su-Ying Liang, Ph.D.
Implementing Universal Lynch Syndrome Screening Across Multiple Healthcare Systems: Identifying Strategies to Facilitate and Maintain Programs in Different Organizations Contexts
Investigators: External PI, Principal Investigator, Su-Ying Liang, Ph.D.
Improving Cancer Care
Investigators: Su-Ying Liang, Ph.D., Harold (Hal) Luft, Ph.D., Ellis C. Dillon, Ph.D.
Lung Cancer in Never Smokers: Incidence, Risk Factors and Molecular Characteristics in Asian American, Native Hawaiian, and Pacific Islander (AANHPI) Women
Investigators: Su-Ying Liang, Ph.D., External PI, Principal Investigator, Harold (Hal) Luft, Ph.D.
Multilevel Study of Lung Cancer Screening Guidelines Implementation (MUST)
Investigators: Jiang Li, Ph.D., MPH, Dorothy Hung, Ph.D., M.A., MPH